Correction to: SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c—Translating Evidence into Practice

Detalles Bibliográficos
Autores principales: Ali, Amar, Bain, Steve, Hicks, Debbie, Newland Jones, Phillip, Patel, Dipesh C., Evans, Marc, Fernando, Kevin, James, June, Milne, Nicola, Viljoen, Adie, Wilding, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778550/
https://www.ncbi.nlm.nih.gov/pubmed/31321747
http://dx.doi.org/10.1007/s13300-019-0670-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778550/
https://www.ncbi.nlm.nih.gov/pubmed/31321747
http://dx.doi.org/10.1007/s13300-019-0670-y

Ejemplares similares